백내장 치료제 시장(2025년) : 미국 및 서유럽 분석(2024-2030년)

What's New:

The new "2025 Cataract Pharmaceuticals Market Report" features newly updated data for both the United States and Western Europe, with expanded analysis of surgeon preferences for infection prevention, pupil dilation, and management of inflammation and pain. This year's report provides deeper insight into the growing adoption of intracameral injections and fixed-combination eye drops, along with a clearer view of how branded, generic, and compounded products are being positioned in clinical practice.

New analysis segments pharmaceutical usage by provider surgical volume, revealing meaningful differences in protocol selection and product mix. The report also includes updated five-year forecasts, expanded coverage of drug and drug-delivery pipelines, and refreshed market share analysis of leading companies to better capture the competitive landscape and where it is heading.

The "2025 Cataract Pharmaceuticals Market Report" provides a comprehensive, data-driven market analysis of the drugs used before, during, and after cataract surgery in the United States and Western Europe. The report examines current utilization patterns and provides five-year forecasts for revenue by product category.

Coverage includes antibiotics, anti-inflammatory agents, mydriatics/cycloplegics, pain management drugs, and intracameral formulations, along with a detailed look at fixed combinations, branded products, generics, and compounded alternatives. The report also explores evolving surgical practices, the growing role of intracameral injections, reimbursement dynamics, and the competitive pipeline shaping the future of cataract pharmaceuticals.

Contents:

This report provides a focused, data-driven view of the cataract pharmaceuticals market in the United States and Western Europe, examining procedure volumes, drug utilization patterns, competitive dynamics, and the evolving role of intracameral and combination therapies. The report covers drugs used at every stage of the cataract surgery process and connects clinical practice trends with market performance, pricing pressure, and pipeline innovation to deliver a clear picture of where the market stands today-and how it is expected to evolve over the next five years.

• Cataract incidence and surgical volumes: trends and market drivers in the US and Western Europe
• Procedure volume forecasts: five-year outlook for cataract surgery and lens-based procedures
• Phakic IOL and RLE trends: evolving role in refractive cataract care
• Antibiotic utilization and sales: perioperative usage patterns and revenue forecasts
• Mydriatics and cycloplegics: usage trends and market outlook
• Anti-inflammatory and pain management drugs: category-level forecasts and demand drivers
• Intracameral injections and fixed combinations: adoption trends and competitive impact
• Branded, generic, and compounded products: competitive dynamics and pricing pressure
• Cataract and refractive surgeon profiles: prescribing behavior and practice characteristics
• Reimbursement and pricing environment: policy trends, pressure points, and implications
• Pipeline products and emerging therapies: innovations poised to reshape the market